ADVFN ADVFN

Hot Features

Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
Medicenna Therapeutics Corp

Medicenna Therapeutics Corp (MDNA)

0.395
0.01
(2.60%)
終了 7月8日 5:12AM

Medicenna Therapeutics Corp (MDNA) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

主要統計と詳細

通貨
0.395
( 2.60% )
買値
0.39
売値
0.395
出来高
186,349
平均取引量 (3 か月)
$ 105,549
財務取引量
-
0.36 日の範囲 0.41
0.36 52 週間の範囲 1.97
時価総額
企業価値
30.327M
前日終値
0.385
始値
0.385
最終取引時間
VWAP
-
歳入
-
純利益
-18.41M
発行済株式数
92,300,201
浮動株比率 (%)
80.79%
機関投資家保有比率 (%)
-
配当利回り
PER
-1.79
株価売上高倍率 (PSR)
-
1 株当たり利益 (EPS)
-0.22
ベータ
1.89

Medicenna Therapeutics Corp について

Medicenna Therapeutics Corp., a clinical-stage immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer, inflammation, and immune-mediated diseases. It develops bizaxofusp, an interleukin- 4 (IL-4) targeted therapy for... Medicenna Therapeutics Corp., a clinical-stage immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer, inflammation, and immune-mediated diseases. It develops bizaxofusp, an interleukin- 4 (IL-4) targeted therapy for the treatment of recurrent glioblastoma. The company also develops MDNA11, an interleukin-2 (IL-2) to activate anti-cancer immune cells over immunosuppressive Tregs; and MDNA113, a tumor-targeting and activatable bifunctional anti-PD-1-IL-2 superkine for cancer. In addition, its preclinical products are MDNA209, an IL-2/IL-15 antagonist for autoimmune diseases, such as multiple sclerosis and graft versus host diseases, including transplant rejection; and MDNA413, an IL-4/IL-13 antagonist to inflammatory, asthma, and atopic dermatitis, as well as other allergic diseases. Medicenna Therapeutics Corp. is headquartered in Toronto, Canada. 詳細を表示

セクター
Healthcare
業界
Biotechnology & Life Sciences
ウェブサイト
本社
Toronto, Canada
設立
-
Medicenna Therapeutics Corp is listed in the Healthcare sector of the トロント証券取引所 with ticker MDNA. The last closing price for Medicenna Therapeutics was $0.39. Over the last year, Medicenna Therapeutics shares have traded in a share price range of $ 0.36 to $ 1.97.

Medicenna Therapeutics currently has 92,300,201 shares in issue. The market capitalisation of Medicenna Therapeutics is $36.46 million. Medicenna Therapeutics has a price to earnings ratio (PE ratio) of -1.79.

MDNA 最新ニュース

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1000.3950.410.36584850.38621367CS
4-0.045-10.22727272730.440.4450.36668340.40696543CS
12-0.235-37.30158730160.630.740.361104340.52017518CS
26-0.545-57.97872340430.941.040.361062160.68508638CS
52-0.505-56.11111111110.91.970.36943270.93658542CS
156-0.285-41.91176470590.682.980.215847421.26709357CS
260-3.415-89.63254593183.813.810.215685171.41810697CS

MDNA - Frequently Asked Questions (FAQ)

What is the current Medicenna Therapeutics Corp share price?
The current share price of Medicenna Therapeutics Corp is $ 0.395
How many Medicenna Therapeutics Corp shares are in issue?
Medicenna Therapeutics Corp has 92,300,201 shares in issue
What is the market cap of Medicenna Therapeutics Corp?
The market capitalisation of Medicenna Therapeutics Corp is CAD 36.46M
What is the 1 year trading range for Medicenna Therapeutics Corp share price?
Medicenna Therapeutics Corp has traded in the range of $ 0.36 to $ 1.97 during the past year
What is the PE ratio of Medicenna Therapeutics Corp?
The price to earnings ratio of Medicenna Therapeutics Corp is -1.79
What is the registered address of Medicenna Therapeutics Corp?
The registered address for Medicenna Therapeutics Corp is 2 Bloor Street West, Toronto, Ontario, M4W 3E2
What is the Medicenna Therapeutics Corp website address?
The website address for Medicenna Therapeutics Corp is www.medicenna.com
Which industry sector does Medicenna Therapeutics Corp operate in?
Medicenna Therapeutics Corp operates in the Biotechnology & Life Sciences sector

MDNA 取引

さらに

取引は遅延しています

リアルタイムの取引を取得するには、アカウントをアップグレードしてください

リアルタイムにアップグレード

最近閲覧した銘柄

Delayed Upgrade Clock